glp 1 agonist review The expanding role of GLP-1 receptor agonists: a narrative of current evidence and future directions GLP-1 Receptor Agonists as Treatments
Description
GLP-1 receptor agonists list Heres a comparison table of the various GLP-1 receptor agonists discussed in previous sections: GLP-1 agonist side effects to consider All GLP-1 receptor agonists have similar side effects
Disclosures Ildiko Lingvay has performed consultancy for AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Intarcia Therapeutics, Janssen Pharmaceuticals, Inc., MannKind Corporation, Novo Nordisk A/S, Sanofi, TARGET PharmaSolutions and Valeritas, Inc
Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: the impact GLP-1 CKD study
and preterm delivery (RR = 1.34
Long-term outcomes and risk of pancreatic cancer in intraductal papillary mucinous neoplasms
In a paradoxical fashion, postprandial hyperglucagonemia a common finding in T2DM contributes to glucose excursions in the fed state
